Mahdieh Motamedi, Reza Vaezi, Seyed Mehdi Alvani, Davood Daneshjafari,
Volume 10, Issue 1 (3-2021)
Abstract
Nowadays, the field of healthcare is facing difficult issues in a way that both public and private sectors are fully aware of their inability to address emerging public health-related issues without the help of the other sector. Accordingly, public-private partnerships are put on the agenda in policy-related issues as a mechanism of cooperation between the public and private sectors to take into account the interests of both parties in the related contracts .From the late of 2019, the world is struggling with a new virus called the coronavirus, which has already cost a lot to the health sector. The partnership between the government and the private sector is very important to get through the corona period since the government alone cannot be responsible for the negative effects of the virus in the field of health. Considering the successes and failures of countries in the implementation of partnership models, a question arises as to how such partnerships for health development strategies can be attractive and effective in developing Islamic countries. In addition to the review of theoretical foundations of the subject and examining the development process of public-private partnerships, the study emphasizes the use of the third sector capacities. It further reviews the endowments and charitable affairs in the framework of multi-sectoral partnerships to develop health in the community with all available potentiality. The theoretical framework of the research includes the four steps of policy-making in the country, creating common perspectives among stakeholders, ensuring key success factors in the project, and reviewing the achievements of participation are considered. These policies are described after classifying and reconstructing the components in the research literature
Moslem Taheri Soodejani, Mohammad Mohammadi Abnavi, Mohammad Hassan Lotfi,
Volume 11, Issue 2 (6-2022)
Abstract
Coronavirus 2019 (COVID-19) is a novel respiratory viral disease which has caused a worldwide emergency due to its rapid spread and high mortality rate causing severe disorders (1). According to the latest reports by World Health Organization(WHO), as of May 2, 2021, 151.8 million people have been infected and 3.2 million deaths have been reported worldwide, most of which occurred in the United States, India, Brazil, France and Turkey respectively. In Iran, 2.5 million people have been infected and 72,000 deaths have been reported (2).
Moslem Taheri Soodejani, Saeed Hosseini, Reyhane Sefidkar, Farzan Madadizadeh, Hossein Fallahzadeh, Ahmad Dehghan, Neda Dehghani Tafti, Mohammad Hassan Lotfi,
Volume 11, Issue 2 (6-2022)
Abstract
Abstract
Introduction: The World Health Organization on March 11, 2020 declared the outbreak of severe acute respiratory syndrome Corona virus 2 disease (COVID-19) a pandemic situation. The main aim of this study was investigating mortality of COVID 19 by considering chronic diseases.
Materials and methods: this study was conducted as a cross-sectional in which all confirmed cases were examined. The variables considered in this study were age, sex, diabetes mellitus, cancers, hypertension, heart diseases, kidney diseases, and liver diseases. Independent sample t test, Chi-square and binary logistic regression were used to data analysis. All statistical analysis was done in SPSS 16 and significant level was set at 0.05.
Results: Out of 22849 PCR and CT scan tests, 16061 ones were positive. According to the confirmed cases, prevalence of COVID-19 was calculated about 0.019. Also hospital case fatality rate and mortality rate were calculated 156 and about 8.2 per 100000 respectively.
Hypertension, and age had significant relationship with morbidity of COVID-19, in other hand, age (OR: 4.51, p<0.001), kidney diseases (OR: 1.84, p<0.001), diabetes mellitus (OR: 1.31, p<0.001), cancer (OR: 2.73, p<0.001), liver diseases (OR: 2.27, p<0.001) had impact on mortality of covid-19. Population Attributable Fraction (PAF) showed that diabetes mellitus, cancers, kidney diseases, and liver diseases had 4.2, 2.4, 1.3, and 0.2 percent, respectively.
Conclusion: age and some underlying diseases increase odds of death due to COVID-19. It seems that preventing high-risk people from being infected is an effective solution to reduce COVID-19 death rate. To do this, health protocols need to be implemented more seriously for these sensitive groups.
